SGM-1019

Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial
CP Wire
Thu, 01/24/19 - 10:51 am
Evotec
Second Genome
NASH
SGM-1019
Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial
Thu, 01/24/19 - 10:12 am
Evotec
Second Genome
NASH
SGM-1019
The Great Drive to Develop Treatments for NASH continues with Second Genome Presenting Data Supporting Development of Its P2X7 Inhibitor, SGM-1019
CP Wire
Mon, 04/9/18 - 03:34 pm
Second Genome
SGM-1019
NASH